102 related articles for article (PubMed ID: 16597680)
21. Effects of dopamine on renal haemodynamics tubular function and sodium excretion in normal humans.
Olsen NV
Dan Med Bull; 1998 Jun; 45(3):282-97. PubMed ID: 9675540
[TBL] [Abstract][Full Text] [Related]
22. Relaxin-induced changes in renal function and RXFP1 receptor expression in the female rat.
Bogzil AH; Ashton N
Ann N Y Acad Sci; 2009 Apr; 1160():313-6. PubMed ID: 19416210
[TBL] [Abstract][Full Text] [Related]
23. Acute effects of the oral administration of midodrine, an alpha-adrenergic agonist, on renal hemodynamics and renal function in cirrhotic patients with ascites.
Angeli P; Volpin R; Piovan D; Bortoluzzi A; Craighero R; Bottaro S; Finucci GF; Casiglia E; Sticca A; De Toni R; Pavan L; Gatta A
Hepatology; 1998 Oct; 28(4):937-43. PubMed ID: 9755229
[TBL] [Abstract][Full Text] [Related]
24. Renal response to pentobarbital anesthesia in rats: effect of interrupting the renin-angiotensin system.
Walker LA; Gellai M; Valtin H
J Pharmacol Exp Ther; 1986 Mar; 236(3):721-8. PubMed ID: 3512818
[TBL] [Abstract][Full Text] [Related]
25. Relaxin ameliorates fibrosis in experimental diabetic cardiomyopathy.
Samuel CS; Hewitson TD; Zhang Y; Kelly DJ
Endocrinology; 2008 Jul; 149(7):3286-93. PubMed ID: 18388190
[TBL] [Abstract][Full Text] [Related]
26. Evidence against the hypothesis that endothelial endothelin B receptor expression is regulated by relaxin and pregnancy.
Kerchner LJ; Novak J; Hanley-Yanez K; Doty KD; Danielson LA; Conrad KP
Endocrinology; 2005 Jun; 146(6):2791-7. PubMed ID: 15761039
[TBL] [Abstract][Full Text] [Related]
27. Effects of CS-905, a novel dihydropyridine calcium channel blocker, on arterial pressure, renal excretory function, and inner medullary blood flow in the rat.
Yagil Y; Miyamoto M; Frasier L; Oizumi K; Koike H
Am J Hypertens; 1994 Jul; 7(7 Pt 1):637-46. PubMed ID: 7946166
[TBL] [Abstract][Full Text] [Related]
28. Relaxin therapy reverses large artery remodeling and improves arterial compliance in senescent spontaneously hypertensive rats.
Xu Q; Chakravorty A; Bathgate RA; Dart AM; Du XJ
Hypertension; 2010 May; 55(5):1260-6. PubMed ID: 20351343
[TBL] [Abstract][Full Text] [Related]
29. Matrix metalloproteinase-2 activity, protein, mRNA, and tissue inhibitors in small arteries from pregnant and relaxin-treated nonpregnant rats.
Jeyabalan A; Kerchner LJ; Fisher MC; McGuane JT; Doty KD; Conrad KP
J Appl Physiol (1985); 2006 Jun; 100(6):1955-63. PubMed ID: 16484357
[TBL] [Abstract][Full Text] [Related]
30. Endogenous relaxin is a naturally occurring modulator of experimental renal tubulointerstitial fibrosis.
Hewitson TD; Mookerjee I; Masterson R; Zhao C; Tregear GW; Becker GJ; Samuel CS
Endocrinology; 2007 Feb; 148(2):660-9. PubMed ID: 17095590
[TBL] [Abstract][Full Text] [Related]
31. Effects of uninephrectomy on renal structural properties in spontaneously hypertensive rats.
Kinuno H; Tomoda F; Koike T; Takata M; Inoue H
Clin Exp Pharmacol Physiol; 2005 Mar; 32(3):173-8. PubMed ID: 15743399
[TBL] [Abstract][Full Text] [Related]
32. The effect of fenoldopam on renal haemodynamics and natriuresis in chronic renal failure.
de Fijter CW; Comans EF; de Vries PM; Oe PL; Roos JC; Smit AJ; Streurman O; Donker AJ
Neth J Med; 1990 Jun; 36(5-6):267-78. PubMed ID: 1975651
[TBL] [Abstract][Full Text] [Related]
33. Restoration of renal responsiveness to atrial natriuretic peptide in experimental nephrotic syndrome by albumin infusion.
Abassi Z; Weissman I; Karram T; Goltsman I; Hoffman A; Better OS; Winaver J
Am J Nephrol; 2013; 38(4):292-9. PubMed ID: 24080549
[TBL] [Abstract][Full Text] [Related]
34. Effect of KATP channel blocker U37883A on renal function in experimental diabetes mellitus in rats.
Vallon V; Albinus M; Blach D
J Pharmacol Exp Ther; 1998 Sep; 286(3):1215-21. PubMed ID: 9732381
[TBL] [Abstract][Full Text] [Related]
35. Impaired vascular responses to relaxin in diet-induced overweight female rats.
van Drongelen J; van Koppen A; Pertijs J; Gooi JH; Parry LJ; Sweep FC; Lotgering FK; Smits P; Spaanderman ME
J Appl Physiol (1985); 2012 Mar; 112(6):962-9. PubMed ID: 22174401
[TBL] [Abstract][Full Text] [Related]
36. Effect of relaxin in two models of renal mass reduction.
Garber SL; Mirochnik Y; Brecklin C; Slobodskoy L; Arruda JA; Dunea G
Am J Nephrol; 2003; 23(1):8-12. PubMed ID: 12373075
[TBL] [Abstract][Full Text] [Related]
37. Glomerular and tubular dynamics in mercuric chloride-induced acute renal failure.
Conger JD; Falk SA
J Lab Clin Med; 1986 Apr; 107(4):281-9. PubMed ID: 3958570
[TBL] [Abstract][Full Text] [Related]
38. PGl2 analogue mitigates the progression rate of renal dysfunction improving renal blood flow without glomerular hyperfiltration in patients with chronic renal insufficiency.
Fujita T; Fuke Y; Satomura A; Hidaka M; Ohsawa I; Endo M; Komatsu K; Ohi H
Prostaglandins Leukot Essent Fatty Acids; 2001 Oct; 65(4):223-7. PubMed ID: 11728176
[TBL] [Abstract][Full Text] [Related]
39. S3226, a novel NHE3 inhibitor, attenuates ischemia-induced acute renal failure in rats.
Hropot M; Juretschke HP; Langer KH; Schwark JR
Kidney Int; 2001 Dec; 60(6):2283-9. PubMed ID: 11737601
[TBL] [Abstract][Full Text] [Related]
40. Effects of a long-acting formulation of octreotide on renal function and renal sodium handling in cirrhotic patients with portal hypertension: a randomized, double-blind, controlled trial.
Ottesen LH; Aagaard NK; Kiszka-Kanowitz M; Rehling M; Henriksen JH; Pedersen EB; Flyvbjerg A; Bendtsen F
Hepatology; 2001 Sep; 34(3):471-7. PubMed ID: 11526531
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
